Non-selective profile distinct from next generation analogues (afamelanotide MC1R selective, bremelanotide MC4R preferential)
Licensed from Zealand Pharma's peptide pla
For example, if youre taking insulin as part of your medication plan, taking GLP-1s alongside this without appropriate changes in your insulin dose could lead to diabetic ketoacidosis
The meta-analysis reported an odds ratio of 28.04 for injection site reactions compared to placebo
By JJ Luime, BW Koes, IJM Hendriksen, A Burdorf, AP Verhagen, HS Miedema, JAN Verhaar | Year: 2004 | Scandinavian Journal of Rheumatology | Volume: 33 | Issue: 2 | Page: 73-81 | Digital Object Identifier: 10.1080/03009740310004667 -------- Disclaimer: The information in this blog post about treating shoulder pain is provided for general informational purposes only and may not reflect current medical thinking or practices